US Biologic develops groundbreaking orally delivered vaccines, focusing on disease prevention for wildlife, companion animals, food animals, and humans. Their innovative technology allows for safe, effective, and cost-efficient delivery of vaccines and therapeutics, addressing significant public health challenges such as Lyme disease and antimicrobial resistance. Collaborating with leading experts, US Biologic commercializes new products by providing funding, regulatory support, and distribution expertise. Their market position is strengthened by partnerships with government agencies and research institutions, aiming to transform global health outcomes through their unique oral-delivery platform.
Something looks off?On-site & Remote